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Presentation to the emergency department after an overdose
of drugs with serious cardiac side effects is common. The
American Association of Poison Control Centers reports
antidepressants as second only to analgesics as a cause of
death from overdose. In the present issue of Critical Care,
Buckley and colleagues evaluate electrocardiogram (ECG)
abnormalities that may be helpful in risk-stratifying patients
after tricyclic antidepressant and thioridazine overdose [1].
This is with particular reference to which patients should
have continuous ECG monitoring.
Despite the availability of continuous cardiac monitoring for
nearly 50 years, there are remarkably few publications
examining the benefits and limitations of continuous ECG
monitoring in patients with a noncardiac primary diagnosis.
Few would doubt the benefits of continuous ECG
recording in intensive care, high dependency and coronary
care units. The patients in these units are perceived to be at
high risk of serious cardiac dysrhythmias, and there is an
appropriately high staffing level to detect and act upon the
information obtained.
Uncertainty arises in the lower intensity, general
medical/surgical wards. Patients perceived to be at low to
moderate risk are frequently attached to continuous ECG
monitoring. However, evidence to support a benefit for
patients that are monitored, or to justify the lack of monitoring
for patients perceived to be at lower risk, is lacking. In
addition, it is not always clear that available staff are
adequately qualified to detect, to interpret and to act
appropriately on the information derived from such systems.
Guidelines suggesting an appropriate strategy for the
monitoring of patients are limited because of the lack of
diagnostic clarity encompassed within many admissions
[2,3]. This may be compounded by multiple diagnoses or
physiological abnormalities resulting in a lack of consensus
regarding the overall level of risk to an individual patient.
Didactic approaches tend to be applicable only to the most
well-defined conditions.
Evidence evaluating tools that may help stratify patients in
terms of their risk of dysrhythmia is therefore very much
welcomed. The question of which patients should be
monitored, however, needs to be broadened; not just who,
but how and why. Clearly the act of monitoring per se is of no
value, there must be a clear plan allowing interpretation of the
data and useful treatment. In the case of tricyclic overdose,
the detection of serious dysrhythmias may prompt treatment
with, for example, systemic alkalinisation [4]. A strategy
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Abstract
Many patients are believed to be at risk of dysrhythmias and are felt to require cardiac monitoring.
These patients may not be deemed ill enough to occupy a high dependency or critical care bed and
are monitored on general wards. Monitoring policies vary widely not only between institutions, but also
between individual medical staff. These variations occur due to differing availability of resources and
due to the lack of consensus regarding the risk for an individual patient. There is no clear evidence that
monitoring patients outside high dependency areas is of benefit; inappropriate use of monitoring may
actually increase patient risk.
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employing continuous monitoring to direct this therapy is
unlikely to be helpful unless there is a high chance of
detection of significant dysrhythmias. Evidence supporting
this strategy in the noncritical care scenario is lacking.
Application of continuous monitoring in these settings may
simply give patients and staff a false sense of security.
Previous studies have used ECG criteria, notably the QRS
duration, the QT interval and the QRS axis, to risk-stratify
patients who have overdosed on tricyclic antidepressants
[5–7]. In the current study, as with previous studies, the
authors find definite associations of these criteria with
dysrhythmia risk, but note that none is in itself a completely
reliable predictor [1,8]. As with previous studies, it is not
possible to say how much of the apparent failure of these
tools is due to the failure of the tool per se, or to failures of
the patient monitoring processes within the study. We do not
know, for example, how many of the patients with ‘no
dysrhythmia’ had asymptomatic tachycardias unnoticed by
the monitoring process.
The authors make the observation that the available ECG
tools might be employed in directing the use of prophylactic
therapies. This argument is attractive as it has a clear
potential to improve patient outcome, rather than merely
directing the application of continuous monitoring. The
authors’ data support the observation that patients with the
extremes of ECG abnormality are at high risk of dysrhythmia;
for example, those with a QRS width greater than 160ms
after a tricyclic overdose. An argument can be made for
prophylactic treatment of such patients. As ever, it is the low-
risk to moderate-risk patients that are difficult to stratify. As
the authors suggest, studies addressing the use of
prophylactic treatments at different levels of perceived risk
from ECG criteria would be desirable, the ECG criteria
remaining useful, although imperfect, tools.
As technology advances and monitoring systems become
more sophisticated, the accuracy of rhythm detection may be
assumed to improve. Automatic alarms can clearly be
beneficial, although it is a common observation that highly
sensitive alarms are frequently ignored due to their relatively
low specificity [9]. It is probable that the human interface will
always remain key.
High-risk patients require monitoring in a well-staffed unit.
Monitoring performed outside these environments is of
questionable value. Tools denoting high risk should be used
not only to direct the application of monitoring, but to
promote monitoring within an appropriate environment and
the consideration of preventative treatments.
Inappropriate monitoring appears likely to persist due to
financial considerations in the immediate future, but it has
elements of self-deceit. Individual hospital units should subject
their monitoring policies to audit and continuous evaluation.
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